116 related articles for article (PubMed ID: 3086430)
1. Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti-L3T4 antibodies.
Sriram S; Roberts CA
J Immunol; 1986 Jun; 136(12):4464-9. PubMed ID: 3086430
[TBL] [Abstract][Full Text] [Related]
2. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
[TBL] [Abstract][Full Text] [Related]
3. Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions.
Lemire JM; Weigle WO
J Immunol; 1986 Nov; 137(10):3169-74. PubMed ID: 2430015
[TBL] [Abstract][Full Text] [Related]
4. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
5. In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis.
Sriram S; Carroll L; Fortin S; Cooper S; Ranges G
J Immunol; 1988 Jul; 141(2):464-8. PubMed ID: 2454992
[TBL] [Abstract][Full Text] [Related]
6. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
7. Treatment of murine lupus with monoclonal antibody to L3T4. II. Effects on immunohistopathology of thymus, spleen, and lymph node.
Ermak TH; Steger HJ; Wofsy D
Lab Invest; 1989 Oct; 61(4):447-56. PubMed ID: 2529396
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
Lavasani S; Dzhambazov B; Andersson M
Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
[TBL] [Abstract][Full Text] [Related]
9. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody.
Waldor MK; Mitchell D; Kipps TJ; Herzenberg LA; Steinman L
J Immunol; 1987 Dec; 139(11):3660-4. PubMed ID: 3500226
[TBL] [Abstract][Full Text] [Related]
10. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.
Gutstein NL; Wofsy D
J Immunol; 1986 Dec; 137(11):3414-9. PubMed ID: 3097122
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
[TBL] [Abstract][Full Text] [Related]
12. T cell requirement for experimental allergic encephalomyelitis induction in the rat.
Ortiz-Ortiz L; Nakamura RM; Weigle WO
J Immunol; 1976 Aug; 117(2):576-9. PubMed ID: 1084904
[TBL] [Abstract][Full Text] [Related]
13. Haplotype-specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies.
Sriram S; Topham DJ; Carroll L
J Immunol; 1987 Sep; 139(5):1485-9. PubMed ID: 3497972
[TBL] [Abstract][Full Text] [Related]
14. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
16. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
Wofsy D
J Immunol; 1986 Jun; 136(12):4554-60. PubMed ID: 3086436
[TBL] [Abstract][Full Text] [Related]
17. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells.
Brostoff SW; Mason DW
J Immunol; 1984 Oct; 133(4):1938-42. PubMed ID: 6236260
[TBL] [Abstract][Full Text] [Related]
18. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
Willenborg DO; Staykova MA; Miyasaka M
J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317
[TBL] [Abstract][Full Text] [Related]
19. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.
Pettinelli CB; McFarlin DE
J Immunol; 1981 Oct; 127(4):1420-3. PubMed ID: 6168690
[TBL] [Abstract][Full Text] [Related]
20. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]